MaxCyte Signs Strategic Platform License with Be Biopharma
Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs...
Source: globenewswire.com
Bio Bcms News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bio Bcms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.